Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Tax Provisions: 2023-2025

Historic Tax Provisions for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to -$31.4 million.

  • Krystal Biotech's Tax Provisions fell 1307.69% to -$31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.0 million, marking a year-over-year change of. This contributed to the annual value of $6.2 million for FY2024, which is 215.37% up from last year.
  • Krystal Biotech's Tax Provisions amounted to -$31.4 million in Q3 2025, which was down 471.95% from $8.4 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Tax Provisions registered a high of $8.4 million during Q2 2025, and its lowest value of -$31.4 million during Q3 2025.
  • Over the past 3 years, Krystal Biotech's median Tax Provisions value was $2.6 million (recorded in 2024), while the average stood at -$988,429.
  • Over the last 5 years, Krystal Biotech's Tax Provisions had its largest YoY gain of 1,669.81% in 2025, and its largest YoY loss of 1,307.69% in 2025.
  • Over the past 3 years, Krystal Biotech's Tax Provisions (Quarterly) stood at $2.0 million in 2023, then soared by 57.61% to $3.1 million in 2024, then plummeted by 1,307.69% to -$31.4 million in 2025.
  • Its Tax Provisions stands at -$31.4 million for Q3 2025, versus $8.4 million for Q2 2025 and $7.9 million for Q1 2025.